Joint Formulary & PAD

Pseudoephedrine hydrochloride - Chronic cough / post-nasal drip

You are here : Home > Formulary Search > Pseudoephedrine hydrochloride - Chronic cough / post-nasal drip

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Linctus
  • Liquid
  • Oral solution
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important
Note MHRA/CHM safety advice. As per CKS for upper airway cough syndrome (post-nasal drip) after other treatments and investigations have failed.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pseudoephedrine hydrochloride
Indication :
Chronic cough / post-nasal drip
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Pseudoephedrine hydrochloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic cough / post-nasal drip.

  • No records returned.